News

Melanoma Risk in the Military Community

By Renee Orcione, MRA Digital Engagement & Communications Manager | 9 November 2023 In News, Prevention, Science, Treatment

Ahead of Veterans Day, the Melanoma Research Alliance (MRA) wishes to recognize the brave individuals who have served and sacrificed for our country. As the largest private nonprofit funder of melanoma research worldwide, we are keenly aware of the important intersection between military service and melanoma.

Read More


Navy Veteran Ashlynn Soellner's Melanoma Journey

By Renee Orcione, MRA Digital Engagement & Communications Manager | 8 November 2023 In Melanoma Stories, Prevention, Treatment

Shortly after her active-duty career in the Navy came to an end, Ashlynn began noticing new moles on her body. She scheduled an appointment with her dermatologist, where a lesion on her shoulder was biopsied. Just a couple weeks later, she received an official diagnosis: she had melanoma. “You never think cancer will happen to you, especially when you are young. I was in complete shock,” said Ashlynn.

Read More


What Veteran's Day Means to the MRA Team

6 November 2023 In News, Prevention

In observation of Veteran's Day - November 11 - we asked the MRA team to create short videos explaining what the day means for them and what they want Veterans and other military personnel to know about their risk for melanoma, other skin cancers, and the importance of sun safety.

Read More


A History of Sunburns and an Early Stage Melanoma Diagnosis: Jill Roth

By Renee Orcione, MRA Digital Engagement & Communications Manager | 26 October 2023 In Melanoma Stories, Treatment

Jill Roth has lived her entire life in Dennison, Ohio. There, she grew up in a close-knit family, eventually started her own, and later became a caretaker to her elderly parents. Now retired, she looks back on her upbringing fondly – especially the countless summers spent by the pool.

Read More


What Melanoma Patients Need to Know about Hepzato Kit

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 23 October 2023 In News, Science, Treatment

You may have heard of Hepzato Kit, also known as Liver-Directed Melphalan, the first liver-directed therapy available for patients with metastatic uveal melanoma who have liver metastases that cannot be surgically removed.

Read More


Adjuvant Therapy: Is More Better or is Less More?

19 October 2023 In Allies & Partnerships, Events, Science, Treatment

In 2021 and 2023, the FDA expanded approval of Keytruda and Opdivo, respectively, in the adjuvant setting to include more patients with melanoma — expanding therapeutic options for a greater number of patients. These decision have created tectonic shifts in the field—opening a range of not only treatment options but also discussion points to which the medical, research, and advocacy community are split.

Read More


Advancing Research after a Rare Diagnosis: Janet Yannelli's Acral Melanoma Journey

By Renee Orcione, MRA Digital Engagement & Communications Manager | 16 October 2023 In Allies & Partnerships, Melanoma Stories, Science, Treatment

“I had never heard of acral melanoma, even though I’m a nurse,” remarked Janet Yannelli, lifelong Maine resident. Acral melanoma is a rare melanoma subtype that accounts for about 1-3% of cases each year. Acral melanoma forms on the palms, soles of feet, or under nails.

Read More


MRA Statement on Expanded Approval of Nivolumab to Patients with Stage 2 Disease

13 October 2023 In News, Science, Treatment

The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to expand eligibility of Bristol Myers Squibb’s Opdivo (nivolumab) to include patients with completely resected Stage IIB and IIC melanoma.

Read More


A Message from Our CEO on Rare Cancer Day

By Marc Hurlbert, PhD, MRA Chief Executive Officer | 30 September 2023 In Melanoma Stories, News, Science

Acral, mucosal, pediatric, and uveal melanomas – what we collectively call rare melanomas – represent an area of profound unmet medical need. Learn what MRA is doing to accelerate research focused on rare melanomas.

Read More


Thriving after Advanced Melanoma at 26: John Elson’s Story

By Renee Orcione, MRA Digital Engagement & Communications Manager | 20 September 2023 In Allies & Partnerships, Melanoma Stories, Treatment

John Elson woke up – on his birthday – and discovered a lump in his neck. The New Yorker wasn’t entirely concerned and initially explained it away as a muscle knot. However, when the lump didn’t go away and he noticed a second one near his armpit, alarm bells started...

Read More


Login

×